| Tag | Content |
|---|
EnhancerAtlas ID | HS018-09990 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr17:72508160-72509840 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NEUROG2 | MA0669.1 | chr17:72509351-72509361 | GACATATGTT | - | 6.02 | | RARA(var.2) | MA0730.1 | chr17:72509229-72509246 | AGGTCAGAAAAAGTTCA | + | 6.08 | | Sox3 | MA0514.1 | chr17:72509814-72509824 | CCTTTGTTTT | + | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_09316 | chr17:72507674-72512040 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 4 | Chromosome | Start | End |
| chr17 | 72508276 | 72508443 | | chr17 | 72508580 | 72509699 | | chr17 | 72508636 | 72509320 | | chr17 | 72508694 | 72509478 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I074511 | chr17 | 72508100 | 72511385 |
|
Enhancer Sequence | TCCCTGTTTC TCCAGGATTG GTCCCTGGTG CCTTATTTGG TTGTTTGCTG AGGACATGTT 60
TTCCTGAATT GTCTGACTGG CCCTGTGGCC TGAGTCACAT TTCAGCTGAA GTCCCAGGCT 120
GCTGCCAACA CCTCCATGGC CTGGCAGTCT TCCACTGGAG TTCAAGTTAC ACTGCTCACC 180
AGAGAATCAC ACGCATTCAG TGTGTGGACT CCATCCTCAC AATCAGATGC TCAGTGTCCA 240
AAATGCTGGG TAAGAAACAT CCTGAAGAAC ACAAATCTGA GATACAGCCT CTTCCAGGCC 300
TGCTCCAAGG CTCCAGACCA ATGCATGAAG CACAGCCTGA GTCCACGTGC CTGAGGGAAC 360
AGACCTCCAA AGCCTACATT GGGAGCTTCC ACCTGGCAAG GAAGGTGTGC TAAGGGCAGA 420
GCTTCCGGCC TCCCTGTTAT CTCAAATGTG GACCTATCAC TGGGGCCCTA GTACTGGGCC 480
CAATACTTGC CTCCACCCTT TGTCAATGCG AACATCCTTC CTCCTGGGGA CAGAGATTTA 540
GAGGTTGACT TTAGAAAAAG CCACTCTCTA TAGATATTTT GAAGCAGCAA GTCCCCCCAG 600
CTTCAAATTT TGTGCTGGCT GAGGCAGCCC AGCCTGGTTG GTGACTAGAA TGGCCTGAAC 660
TGGGAGTCAT GGAAACTGAC TCAGAGTCAT GGAAAGTTGG GGCTGAAAGG GGAAGAAGAG 720
GTCATGCACC ATCCGTCTTG CAGCTATAAA AACTAAGGTT TAGGTTGGTG AGGGGGTGTA 780
CCCGAAGGAT GACTCAAAGG GTACTTCACG GGTAAAGGAA CTCAGCTCAA ATAAGGTGAC 840
TCAAGTCTAT TTACAGCCTT GTCCAGTGTG GACTCAAGAA TAGCCTGGCC TACCACCCTG 900
AGCTGTCAGG GAGGACAGAT GAGATGGACA TTGTGAAAAT GGGGTACTGC CAGCCTTTAA 960
AATGCGGCGA GTGCACAAGT CACGCAGTGC TGTTATCAAC TCATGATATA AGTTCCTCTT 1020
CCCTCCCCCG ACTGCCTGTG TTGAGTCTCA AATTCATCCC ACTGCAGGGA GGTCAGAAAA 1080
AGTTCAGAAC TTCTTTCTGA CCTCCCTCTT GTGGGATTTA ATGAGGACAT GAAGTGGTGA 1140
CATTGAGGTG GGAGTTAAGG AGAATGTGCT GGGCTTGGGG CCCAGCAGAT GGACATATGT 1200
TACCTGTGCC CCTGGGGATG ATTCTACCTT CTAAAATGGG CCATGGAAAC CTGGTTTCAT 1260
GTGGTTGGGT CAATCCCCCC AGTGCTTCTG AGGTTGATGA GTTAAACGAT GCAAAGGCCA 1320
TGGTTGGGAG ATCTCCTCTT GGGATACGAC TTTGGTGAAT TTACCTGGGT CTGGTCCTCA 1380
TTCCTGCAAA TCTAGAACCC GACCACCATC CAGACAAGAA GAGAGACTGA GACCCTACAA 1440
TAACTCAAGT GATTTATTTT GGGGACACTC CTTTCCAGGA AGCTGAATGC TTGTGACCCT 1500
CATCTGTTTT TCTGATTTCA GCTGCCTGGG AGGTTGCCTG AGCAGGCAGG AGGCAGCTCA 1560
TGGGCATGGA CTTGAACTGA TGCCTCGAAT GGCCTGCCTG GCCTTTGTCT TTCTTTATGT 1620
TCCATTACCA AATATTCTGC TCCTGGAATC ACAGCCTTTG TTTTTATTTA TTTATTTATT 1680
|
